The MELD score in advanced liver disease: Association with clinical portal hypertension and mortality

Experimental and Clinical Transplantation

Volumn 4, Issue 1, 2006, Pages 395-399

  Saab, Sammy ^a,d   Landaverde, Carmen ^b   Ibrahim, Ayman B ^a   Durazo, Francisco ^a   Han, Steven ^a   Yersiz, Hasan ^a   Farmer, Douglas G ^a   Ghobrial, R Mark ^a   Goldstein, Leonard I ^a   Tong, Myron J ^c   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Liver transplantation; MELD; Outcome

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; LABORATORY TEST; LIVER HEMORRHAGE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PREDICTION; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL PATIENT; UNITED STATES; UNIVARIATE ANALYSIS; VARICOSIS;

ADULT; AGED; ASCITES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33745621288     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-1874
2. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004; 24: 1-8
3. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-858
4. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470
5. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96
6. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580
7. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12-18
8. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004; 4: 1798-1804
9. Kamath PS, Kim WR. Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transpl 2003; 9: 19-21
10. Runyon BA; Practice Guidelines Committee; American Association of for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-856
11. Blei AT, Cordoba J; Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-1976
12. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903
13. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128
14. Ruf AE, Kremers WK, Chavez LL, Descalzi A Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-343
15. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-810
16. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002; 162: 323-328
17. Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32: 157-170
18. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
19. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002; 35: 1282-1284
20. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-885